Article: Switzerland-Based Eye-Care Products Maker Alcon Reports 76 Percent Profit Rise.

By Roger Yu, The Dallas Morning News Knight Ridder/Tribune Business News

Oct. 25--Eye-care products maker Alcon Inc. said Thursday that its third-quarter profit soared 76 percent to $125.1 million as it cut expenses and saw greater demand for its pharmaceuticals, particularly the glaucoma medication Travatan.

Alcon, which went public in March, said earnings per share adjusted for IPO-related expenses were 40 cents in the quarter, exceeding analysts' consensus estimate of 34 cents. But on a day when the Dow Jones industrial average fell 2.1 percent to 8,317.34, Alcon shares fell 99 cents to $38.01.

The company, whose principal U.S. ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!